The conference was held in Khiva, Uzbekistan on May 19-20, 2023. The event was organized by the Ministry of Health and the Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Republic of Uzbekistan.

More than 250 delegates from India, Republic of Korea, Turkey, Egypt, Russian Federation, United Kingdom and Kyrgyzstan attended the event.

Pharmasyntez presented its pipeline of antineoplastic drugs that aroused great interest among the medical community. Representatives of the company spoke with oncologists of the Republic about the processes of drug development and production, as well as about the company's research base. Colleagues exchanged experience for further cooperation.

For many years, Pharmasyntez has been a partner of specialized events devoted to the fight against oncological diseases. The company's product portfolio already includes more than 45 names of cytostatic drugs, 99% out of which are included in the List of Vital and Essential Drugs (VED) of the Ministry of Health of the Russian Federation. More than 50% of the substances used in the production of these drugs are domestically manufactured. They are mainly produced in the BratskChemSyntez plant, which is a part of the company.